Gentiva Health Services (NASDAQ:GTIV) is in a space that's often overlooked by health care analysts; the company provides a variety of important health care services, such as nursing, to patients in both hospices and in their own homes.
Gentiva reported its third-quarter earnings today and posted a 6% drop in year-over-year revenue. Despite these seemingly poor results, its share price spiked an impressive 22%. What caused this surge? Can investors compare these report to upcoming earnings releases from competitors Amedisys (NASDAQ:AMED) and the LHC Group (NASDAQ:LHCG)?
In the following video, health care analysts Max Macaluso and David Williamson discuss this quarter's earnings and why Gentiva's share price soared.
Max Macaluso, Ph.D. and David Williamson have no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.